ストックスクリーナーアプリを入手
47.99
1.78%
-0.87
アフターアワーズ：
47.99
Qiagen Nv (QGEN) 最新ニュース
Qiagen Receives Notification of BlackRock’s Significant Stake - TipRanks
Relative strength of Qiagen N.V. in sector analysis2025 Market Overview & Community Consensus Picks - Newser
Will Qiagen N.V. rebound enough to break evenJuly 2025 Spike Watch & Real-Time Stock Entry Alerts - Newser
Qiagen Announces Major BlackRock Shareholding - MSN
Qiagen N.V. stock trend forecastTrade Performance Summary & Risk Controlled Swing Alerts - Newser
Real time pattern detection on Qiagen N.V. stock2025 Price Targets & Long-Term Investment Growth Plans - Newser
Will Qiagen N.V. outperform the marketOil Prices & Weekly Top Gainers Trade List - Newser
Will Qiagen N.V. stock go up soonWeekly Investment Recap & Smart Swing Trading Alerts - Newser
Long term hold vs stop loss in Qiagen N.V.2025 Risk Factors & Free Long-Term Investment Growth Plans - Newser
Is Qiagen N.V. showing signs of accumulationJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - Newser
Qiage announces $300M buyback plan - MSN
Is Qiagen N.V. currently under institutional pressureJuly 2025 Breakouts & Growth Focused Stock Reports - theviewers.co.kr
What are analysts’ price targets for Qiagen N.V.July 2025 Gainers & Free Weekly Chart Analysis and Trade Guides - theviewers.co.kr
Is Qiagen N.V. stock showing strong momentumJuly 2025 Technicals & Daily Oversold Stock Bounce Ideas - theviewers.co.kr
Qiagen Releases Q2 2025 Financial Report Highlighting Asset Growth - MSN
Have Qiagen Insiders Been Selling Stock? - simplywall.st
Chart based exit strategy for Qiagen N.V.Treasury Yields & Safe Swing Trade Setup Alerts - Newser
PTA-CMS: QIAGEN N.V.: Release of a capital market information - TradingView
Qiagen N : Second Quarter 2025 SEC Filing - MarketScreener
Qiagen: Diagnostics Vs. Life Sciences Pair Trade Analysis (NYSE:QGEN) - Seeking Alpha
Can swing trading help recover from Qiagen N.V. losses2025 Trading Recap & Scalable Portfolio Growth Methods - Newser
What makes Qiagen N.V. stock price move sharply2025 Stock Rankings & Verified Swing Trading Watchlists - 더경남뉴스
QIAGEN NV : Gets a Buy rating from Deutsche Bank - MarketScreener
Institutional scanner results for Qiagen N.V.Quarterly Performance Summary & Accurate Technical Buy Alerts - Newser
Real time social sentiment graph for Qiagen N.V.Day Trade & Smart Allocation Stock Reports - Newser
How moving averages guide Qiagen N.V. tradingMarket Volume Report & Free Low Drawdown Momentum Trade Ideas - Newser
Qiagen Manager Sells $1.23M in Shares for Asset Allocation - AInvest
QIAGEN Executive Sells Significant Shareholding - TipRanks
Qiagen Executive Sells Significant Shareholding - TipRanks
QIAGEN Manager Sells Shares for Asset Allocation - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Qiagen N.V.’s volatility index tracking explained2025 Technical Overview & Safe Capital Growth Tips - Newser
QIAGEN N.V. Announces Managerial Share Sale by Roland Sackers - TipRanks
Qiagen N.V. Reversal Rally May Surprise Bears2025 Stock Rankings & Fast Moving Market Watchlists - metal.it
Upbeat Q2 Results and Raised Outlook Could Be a Game Changer for Qiagen (QGEN) - simplywall.st
Sector Leaders Rotate Capital Into Qiagen N.V.July 2025 Spike Watch & AI Based Buy/Sell Signal Reports - newsyoung.net
Qiagen N.V. shares rise 1.09% intraday as DAX index climbs toward record high. - AInvest
Will Qiagen N.V. Hold Gains Into CloseJuly 2025 Fed Impact & Growth Focused Investment Plans - sundaytimes.kr
Sentiment Turns Positive on Qiagen N.V. — Reversal AheadJuly 2025 Movers & Long-Term Capital Growth Strategies - classian.co.kr
PATENT—Fed. Cir.: Qiagen did not infringe Labcorp's DNA sequencing preparation patents; $4.7M jury verdict reversed - VitalLaw.com
How Investors Are Reacting To Qiagen (QGEN) Return to Profitability and Upgraded 2025 Sales Outlook - simplywall.st
Contradictions Unveiled: Qiagen's 2025Q2 Earnings Call Highlights Divergent Views on Market Performance and Growth - AInvest
US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche - Yahoo Finance
STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories - GlobeNewswire Inc.
Why Qiagen (QGEN) International Revenue Trends Deserve Your Attention - sharewise.com
Investors Interested In Qiagen N.V.'s (NYSE:QGEN) Earnings - 富途牛牛
Europe Molecular Oncology Diagnostics Market Research Report 2024-2033 | Competitive Analysis of Biocartis Group, bioMerieux, F. Hoffmann-La Roche, QIAGEN - Yahoo Finance
What the charts say about Qiagen N.V. todayPortfolio Risk Summary & Growth Focused Stock Reports - Newser
A Quick Look at Today's Ratings for Qiagen NV(QGEN.US), With a Forecast Between $49 to $50 - 富途牛牛
Qiagen N.V. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - simplywall.st
Why Qiagen N.V. stock attracts strong analyst attentionMulti-Year Breakout Candidates - sisain.net
0.51%
0.31%
大文字化:
|
ボリューム (24 時間):